PubRank

J P Maciejewski

Author PubWeight™ 57.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 2011 2.82
2 Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000 2.42
3 Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 2010 2.01
4 Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood 2001 1.89
5 Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia 2013 1.84
6 Correction of the PNH defect by GPI-anchored protein transfer. Blood 1998 1.55
7 UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation. Leukemia 2008 1.39
8 Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes. Leukemia 2007 1.37
9 Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 1995 1.33
10 Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 1996 1.32
11 Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia 2012 1.31
12 Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 1997 1.26
13 Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest 2001 1.25
14 Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency. Blood 1997 1.24
15 TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. Leukemia 2009 1.23
16 Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood 1998 1.19
17 Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS. Leukemia 2007 1.19
18 Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion. Oncogene 2012 1.16
19 Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies. Leukemia 2013 1.10
20 Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood 1997 1.04
21 Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. Blood 1997 1.03
22 Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J 2012 1.02
23 Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp Hematol 2001 1.02
24 Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells. Br J Haematol 1997 0.98
25 Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in 'normal' phenotype cells. Leukemia 2005 0.98
26 Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells. Br J Haematol 1997 0.97
27 Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria. Leukemia 2010 0.96
28 Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation. Blood Cancer J 2013 0.93
29 Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients. Leukemia 2005 0.92
30 Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients. AIDS 1997 0.91
31 Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors. Bone Marrow Transplant 2007 0.90
32 CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. Leukemia 2012 0.88
33 Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2008 0.88
34 In vitro infection of megakaryocytes and their precursors by human cytomegalovirus. Blood 2000 0.87
35 Cytomegalovirus-specific regulatory and effector T cells share TCR clonality--possible relation to repetitive CMV infections. Am J Transplant 2011 0.87
36 Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes "Why? Why? Why?". J Clin Invest 2000 0.86
37 Apoptosis induced by human cytomegalovirus infection can be enhanced by cytokines to limit the spread of virus. Exp Hematol 1999 0.84
38 Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008 0.84
39 Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome. Leukemia 2007 0.84
40 Hypocupremia and bone marrow failure. Haematologica 2008 0.83
41 Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1. Blood 1995 0.82
42 Impact of immunogenetic polymorphisms in bone marrow failure syndromes. Mini Rev Med Chem 2011 0.82
43 Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. Leukemia 1998 0.82
44 The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection. J Clin Invest 1998 0.82
45 Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis. Blood 1998 0.81
46 Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential. Exp Hematol 1998 0.81
47 Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant. Bone Marrow Transplant 1999 0.80
48 Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 2003 0.79
49 The role of FAS-mediated apoptosis in chronic myelogenous leukemia. Leuk Lymphoma 2000 0.77
50 Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts. Leukemia 2013 0.77
51 Nitric oxide and cell survival: megakaryocytes say "NO". J Lab Clin Med 2001 0.76
52 Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia 2015 0.76
53 CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia. Blood Cancer J 2013 0.76
54 Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome. Leukemia 2017 0.75
55 Epidemiology and risk factors for infections in myelodysplastic syndromes. Transpl Infect Dis 2013 0.75